23andMe Holding Co - Warrants (16/06/2026) Profit Margin

23andMe Holding Co - Warrants (16/06/2026) (MEUSW) currently reports a profit margin of -134.54% as of June 2025. That compares with -317.03% in the prior-year period — up 57.6% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore 23andMe Holding Co - Warrants (16/06/2026)'s profit margin history and peer comparisons.

23andMe Holding Co - Warrants (16/06/2026)'s profit margin increased from -317.03% to -134.54% — a 57.6% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

23andMe Holding Co - Warrants (16/06/2026)'s profit margin of -134.54% is lower than the Healthcare sector average of 14.34%. That is roughly 1037.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but 23andMe Holding Co - Warrants (16/06/2026)'s current -134.54% should be judged against Healthcare norms (sector average: 14.34%) and against MEUSW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -134.54%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for 23andMe Holding Co - Warrants (16/06/2026), and consider following MEUSW for alerts when major investors trade the stock.